Химерний рецептор антигена (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Химерний рецептор антигена" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

4^th place

5^th place

2^nd place

4^th place

137^th place

887^th place

doi.org

Srivastava S, Riddell SR (August 2015). Engineering CAR-T cells: Design concepts. Trends in Immunology. 36 (8): 494—502. doi:10.1016/j.it.2015.06.004. PMC 4746114. PMID 26169254.
Sadelain M, Brentjens R, Rivière I (April 2013). The basic principles of chimeric antigen receptor design. Cancer Discovery. 3 (4): 388—398. doi:10.1158/2159-8290.CD-12-0548. PMC 3667586. PMID 23550147.
Hartmann J, Schüßler-Lenz M, Bondanza A, Buchholz CJ (September 2017). Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts. EMBO Molecular Medicine. 9 (9): 1183—1197. doi:10.15252/emmm.201607485. PMC 5582407. PMID 28765140.
Tang XJ, Sun XY, Huang KM, Zhang L, Yang ZS, Zou DD, Wang B, Warnock GL, Dai LJ, Luo J (December 2015). Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy. Oncotarget. 6 (42): 44179—44190. doi:10.18632/oncotarget.6175. PMC 4792550. PMID 26496034. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Zhang H, Zhao P, Huang H (December 2020). Engineering better chimeric antigen receptor T cells. Experimental Hematology & Oncology. 9 (1): 34. doi:10.1186/s40164-020-00190-2. PMC 7709221. PMID 33292660.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)

Srivastava S, Riddell SR (August 2015). Engineering CAR-T cells: Design concepts. Trends in Immunology. 36 (8): 494—502. doi:10.1016/j.it.2015.06.004. PMC 4746114. PMID 26169254.
Sadelain M, Brentjens R, Rivière I (April 2013). The basic principles of chimeric antigen receptor design. Cancer Discovery. 3 (4): 388—398. doi:10.1158/2159-8290.CD-12-0548. PMC 3667586. PMID 23550147.
Hartmann J, Schüßler-Lenz M, Bondanza A, Buchholz CJ (September 2017). Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts. EMBO Molecular Medicine. 9 (9): 1183—1197. doi:10.15252/emmm.201607485. PMC 5582407. PMID 28765140.
Tang XJ, Sun XY, Huang KM, Zhang L, Yang ZS, Zou DD, Wang B, Warnock GL, Dai LJ, Luo J (December 2015). Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy. Oncotarget. 6 (42): 44179—44190. doi:10.18632/oncotarget.6175. PMC 4792550. PMID 26496034. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Zhang H, Zhao P, Huang H (December 2020). Engineering better chimeric antigen receptor T cells. Experimental Hematology & Oncology. 9 (1): 34. doi:10.1186/s40164-020-00190-2. PMC 7709221. PMID 33292660.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)

Srivastava S, Riddell SR (August 2015). Engineering CAR-T cells: Design concepts. Trends in Immunology. 36 (8): 494—502. doi:10.1016/j.it.2015.06.004. PMC 4746114. PMID 26169254.
Sadelain M, Brentjens R, Rivière I (April 2013). The basic principles of chimeric antigen receptor design. Cancer Discovery. 3 (4): 388—398. doi:10.1158/2159-8290.CD-12-0548. PMC 3667586. PMID 23550147.
Hartmann J, Schüßler-Lenz M, Bondanza A, Buchholz CJ (September 2017). Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts. EMBO Molecular Medicine. 9 (9): 1183—1197. doi:10.15252/emmm.201607485. PMC 5582407. PMID 28765140.
Tang XJ, Sun XY, Huang KM, Zhang L, Yang ZS, Zou DD, Wang B, Warnock GL, Dai LJ, Luo J (December 2015). Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy. Oncotarget. 6 (42): 44179—44190. doi:10.18632/oncotarget.6175. PMC 4792550. PMID 26496034. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Zhang H, Zhao P, Huang H (December 2020). Engineering better chimeric antigen receptor T cells. Experimental Hematology & Oncology. 9 (1): 34. doi:10.1186/s40164-020-00190-2. PMC 7709221. PMID 33292660.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)